Powerful Medical

🔬 We are delighted to share that the Belgian Central Ethics Committee has officially granted approval for the AI-ECG TIMI Study across all three Belgian sites—making Belgium the first of the three participating countries to receive approval. Additionally, the first patient has officially been enrolled in the study. The AI-ECG TIMI Study is a novel, international, multi-center observational study leveraging AI to enhance the detection and management of acute coronary syndromes (ACS). Conducted across 5+ centers in Belgium, Austria, and Italy, the study spans over 700 patients and focuses on correlating 12-lead ECG patterns with coronary vessel status during ACS. 📖 Learn more about the study and its impact in our blog: https://lnkd.in/duYrT5XK #TIMIStudy #ClinicalValidation #CardiologyAI #PMcardio

🎤 Our CEO, Martin Herman, recently spoke at the ITAPA AI 2024 conference, sharing the story of how and why Powerful Medical was founded, the key steps that shaped our journey, and the lessons learned along the way. During the interview, he discussed the importance of choosing the right investors, the challenges and successes of expanding into international markets, and the path to securing investment from the European Innovation Council and SMEs Executive Agency (EISMEA). It was a great opportunity to reflect on innovation, resilience, and scaling impact in healthcare. Thank you, #ITAPA and Dávid Tvrdoň, for hosting such a thought-provoking discussion! #PowerfulMedical #AIinHealthcare

🫀 Announcing the AI ECG TIMI study: the first study to record 12-lead ECGs during invasive coronary angiography in all-comer ACS patients, aiming to uncover the dynamic ECG patterns and the corresponding pathophysiology of culprit vessels. With an imminent paradigm shift in the management of STEMI, this research will address several critical questions: > What is the pathophysiological correlation between STEMI-equivalent ECG patterns and the culprit coronary blood flow? > Can AI-powered ECG accurately distinguish between actively occluded and recanalized culprit vessels? > What is the most accurate, angiographic definition of acute coronary Occlusion Myocardial Infarction (OMI)? This study will enroll over 700 patients across 9 centers in 3 countries led by: 🇧🇪 Heart Center Aalst AZORG OLV Ziekenhuis Aalst-Asse-Ninove 🇮🇹 Sapienza Università di Roma Azienda ospedaliero-universitaria Sant'Andrea 🇦🇹 Medizinische Universität Graz I am honored to collaborate on this EIC Accelerator-funded study alongside world-class interventional cardiologists and co-chairs of the steering committee, Emanuele Barbato and Jozef Bartunek, and a remarkable group of national principal investigators: Adriaan Wilgenhof, Marta Belmonte, and Gábor G. Tóth!

🔬 Announcing the AI-ECG TIMI Study: A Multi-Center Validation Across Three Countries 🇧🇪 🇦🇹 🇮🇹 We are proud to launch a novel, international, multi-center observational study focused on leveraging AI to enhance the detection and management of acute coronary syndromes (ACS). 🗺️ Running from December 2024 to December 2025, the AI-ECG TIMI Study spans three countries—Belgium, Austria, and Italy—with 5+ centers and over 700 patients, representing a significant milestone in advancing global cardiovascular care. The study’s objectives are far-reaching, with a focus on bridging critical evidence gaps in ACS research, including: 🔵 Lack of Standardized ECG Data at Critical Moments 🔵 Objective Quantitative Assessment of Microvascular Perfusion in Culprit Vessels 🔵 Dynamic Nature of Acute Coronary Syndromes 🔵 Untapped Potential of AI-Based ECG Interpretation 🔵 The Potential of ECG as a Non-invasive Marker of Reperfusion Success 🔵 Lack of Real-World Validation In addition to addressing these challenges, the AI-ECG TIMI Study is centered on achieving three core goals: ➡️ Correlating 12-lead ECG patterns with coronary vessel status during ACS. ➡️ Validating AI-driven diagnostic accuracy for real-time cardiac care. ➡️ Bridging critical gaps in evidence to enhance clinical outcomes and streamline workflows. This ambitious initiative marks a crucial step in our mission to transform cardiac diagnostics, equipping clinicians with innovative tools for faster, more precise intervention. We look forward to sharing updates on this impactful journey. For more details, read our blog: https://lnkd.in/dwsmnBfG #CardiologyAI #ClinicalValidation #TIMIStudy #PMcardio

“There was a group from Europe at AHA that took a bunch of angiograms with occluded arteries and used that as the central truth, had the associated EKGs, fed that all into the AI machine” I am proud to be a European from Slovakia working on technology already impacting millions of heart attack patients each year world wide! Great podcast with some of the world leaders in cardiology C. Michael Gibson, M.S., M.D. and Robert A. Harrington, Manesh Patel, MD on a new emerging paradigm. https://lnkd.in/deHDK2pB

🎥 Martin Herman Sits Down for an Exclusive Interview with LSI Europe to Talk Transforming Cardiac Care Speaking from Sintra, Portugal, CEO of Powerful Medical joins LSI Europe to share insights on how AI-powered diagnostics and seamless coordination are revolutionizing cardiac care. Martin delves into how #PMcardio is optimizing workflows and improving diagnostic accuracy on a global scale, highlighting its transformative impact and Powerful Medical’s mission to shape the future of healthcare. 🌍 🔗 Watch the full interview here: https://lnkd.in/d6XVE3Qg #LSIEurope2024 #PowerfulMedical #CardiologyAI #SavingLives

We're thrilled to announce PMcardio’s expansion into telemedicine, empowering pharmacy and primary care-based ECG screening across Europe! 🩺 PMcardio, our CE-certified AI powered medical device, now streamlines cardiac diagnostics beyond hospital walls. By integrating into telemedicine workflows, we’re supporting faster, more efficient care for patients screened at first point of contact. 💡 Why It Matters: - Improved Accessibility: Brings specialized cardiac care closer to patients. - Enhanced Efficiency: Supports clinicians in managing high patient volumes. - Diagnostic accuracy: Delivers AI-driven precision for patients in out-of-hospital settings, trained on millions of patient records. 🔗 Read more about how we’re shaping the future of accessible heart health with AI: https://lnkd.in/dib_xSPF #Telemedicine #CardiologyAI #PowerfulMedical #PMcardio

🩺 “We improved care for over 3000 chest pain patients, and we're particularly proud to have reduced the door-to-balloon time in the STEMI equivalent cohort by 13 hours.” – Martin Herman, CEO of Powerful Medical. At the American Heart Association Health Tech Competition 2024, Martin introduced PMcardio, our AI-powered cardiovascular diagnostics platform. Trained on millions of patient outcomes, PMcardio diagnoses 39 cardiac conditions from any 12-lead ECG. Central to PMcardio is our AI-powered chest pain pathway, designed to transform acute heart attack care. By improving detection accuracy, streamlining care in clinical settings and reducing false positives, it sets a new standard in cardiovascular diagnostics. 🎥 Watch Martin’s winning presentation to learn more about PMcardio transforming cardiac care. #AHA2024 #PowerfulMedical #AIInHealthcare

🫀 “Our technology enables more accurate detection of acute heart attacks, with the potential to prevent over 12,000 excess deaths annually in the US,” – Robert Herman, MD, Chief Medical OfficerAt the American Heart Association Health Tech Competition 2024, Dr. Herman emphasized the importance of equitable access to accurate diagnostics and treatment of acute heart attacks, explaining how #PMcardio delivers the same high-quality diagnostics, regardless of patient demographics. 🎥 Watch his presentation for the Best Science Startup that earned recognition from top physicians, scientists, and industry leaders. 🔗 For the full video, click here: https://lnkd.in/d6BzNQ7E #AHA2024 #PowerfulMedical #AIInHealthcare

"This technology is really going to change and save lives, I know absolutely from first-hand experience!" - Star Jones, announcing Powerful Medical as the winner of the 2024 American Heart Association Health Tech Competition! PMcardio is an AI-powered ECG interpretation and clinical care coordination platform. It enables faster diagnosis and management of acute heart attacks, which affect over 800,000 Americans, like Star Jones, in the USA each year.